Augmentin For Suspension
Product Images NDC 71297-240

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Augmentin (NDC 71297-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegis Holdings, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label 100)

Augmentin 125 mg/31.25 mg per 5 mL oral suspension label by Allegis Holdings, LLC, NDC 71297-240. The label includes mixing instructions, storage requirements, and dosage details for the 100 mL bottle when reconstituted. Active ingredients are amoxicillin and clavulanate potassium.*

FDA Label Image

Label (Label 150)

Augmentin 125 mg/31.25 mg per 5 mL oral suspension bottle label by Allegis Holdings, LLC. The label details directions for mixing, dosage instructions, storage requirements including refrigeration and discarding after 10 days, with active ingredients amoxicillin and clavulanate potassium. The bottle contains 150 mL when reconstituted.*

FDA Label Image

Table (Table 3)

A data table showing dosing regimens for Amoxicillin and Clavulanate Potassium oral suspension related to infection treatment. It compares dosing every 12 hours versus every 8 hours for different infection severities such as otitis media and sinusitis, providing weight-based dosages in mg/kg/day. Footnotes relate to formulation availability and therapy duration for acute otitis media.*

FDA Label Image

Table (Table 6)

A data table presenting pharmacokinetic values for amoxicillin and clavulanate potassium at various doses and regimens. It shows Cmax (peak concentrations in mcg/mL) and AUC0-24 (area under the curve in mcg*h/mL) for both active ingredients, including mean values with standard deviations, based on 14-15 normal adults dosed orally at meal start.*

FDA Label Image

Table (Table 7)

A data table comparing pharmacokinetic parameters, including peak concentration (Cmax) and area under the curve (AUC 0-24), for Amoxicillin and Clavulanate potassium administered as a 400 mg/57 mg dose in 5 mL suspension versus 1 chewable tablet, showing mean values and standard deviations for 28 adults.*

FDA Label Image

Structure-amoxicillin (Structure Amox 1)

Chemical structure of Amoxicillin and Clavulanate Potassium showing the molecular arrangement including a phenol group, β-lactam ring, and attached functional groups, annotated with three water molecules (3H2O).*

FDA Label Image

Structure-clav-acid (Structure Clav 1)

Chemical structure of Amoxicillin and Clavulanate Potassium showing the molecular framework, including a beta-lactam ring and attached functional groups relevant to the active ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.